eev/mcev – recent market trends · proprietary and confidential. for towers watson and towers...
TRANSCRIPT
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
EEV/MCEV – Recent Market Trends
Dominique Lebel June 2013
© 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Agenda
Background on EEV/MCEV 2012 EEV/MCEV publication highlights EEV/MCEV trends
1
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
The origins of EV in life financial reporting
2
Addressed inadequacies in statutory/GAAP reporting: High new business strain/ deferral of profit emergence No insight into new business profitability
EV used to show value creation and for management incentives
VIF included as asset on holding company balance sheet Banks reported change in EV as profits in their primary
accounts
towerswatson.com
VIF
VNB
Net Assets
VIF
Net Assets
© 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
1988 1993 1998 2003 2008 2013
All Stocks Life Index
Developments in financial reporting
Source: Towers Watson analysis of Bloomberg data
Statutory/GAAP Traditional EV EEV/MCEV Cash and Capital
Economic capital/risk
EEV Principles published (2004)
MCEV Principles published (2008)
Prudential reports on an “Accruals basis” at YE 1992
Pearl appraisal value, 1989
First MCEVs published 2003
90s bull market
Dotcom bubble burst
Global Financial
Crisis
3
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Within EEV, a number of approaches have been used to allow for risk
EEV allowance for risk
Top-down Bottom-up
Unadjusted WACC
Adjusted WACC
Product- specific
beta
Stochastic ‘real world’
Indirect MCEV
Direct MCEV
4
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
EEV vs. MCEV
Assets
C&S
Liabilities
PVFP @ RDR**
VIF
TVOG
Cost of NHR
Frictional Cost of
Required Capital
*Risk Adjusted Discount Rate **Market Consistent Discount Rate
PVFP @ RDR*
VIF
TVOG
Cost of Required Capital
Market Value of Free Surplus + Required Capital
Market Value of Free Surplus + Required Capital
Market Consistent Embedded Value European Embedded Value (Top Down Approach)
EEV MCEV
FVL
Assets
C&S
Liabilities
5
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
CFO Forum – Recent Statements
April 2011 The CFO Forum withdrew the intention that the Market Consistent Embedded Value (MCEV) Principles© are the only recognized format of embedded value reporting from 31 December 2011. The withdrawal reflects the ongoing development of insurance reporting under Solvency II and IFRS. The CFO Forum remains committed to the value in supplementary information, including embedded value.
September 2011 The CFO Forum released interim transitional guidance for embedded value reporting in advance of the effective date of Solvency II: For reporting dates on or before 30 June 2012, there is no requirement to make allowance for the developing European regulatory regime (Solvency II) and associated consequences when complying with the European Insurance Market Consistent Embedded Value (MCEV) Principles© or the European Embedded Value Principles (EEV). This interim transitional guidance reflects that the full implications of Solvency II will not be known with sufficient certainty before the second quarter of 2012 at the earliest.
December 2011 In response to current sovereign debt market conditions and complementary to the transition guidance published in September 2011, waiting for the finalization of Solvency II, the CFO Forum members are working collaboratively on the application of the Market Consistent Embedded Value (MCEV) Principles© to ensure that companies have access to the best possible guidance on the subject and that the application is appropriate to the current market conditions and to the needs of the users of financial statements. Including an allowance for the current sovereign debt market conditions as a component of the reference rate in embedded value reporting or disclosing a sensitivity as supplementary information of reported embedded value to such parameters where it is deemed appropriate would represent an initial step towards the expected convergence of MCEV with the developing European regulatory regime (Solvency II) on the matter. 6
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
CFO Forum – Recent Statements
September 2012 The CFO Forum released revised interim transitional guidance for embedded value reporting in advance of the effective date of Solvency II: • The revised interim transitional guidance is effective for all reporting dates until such time
that there is full clarity on Solvency II, including the effective date and the publication of all relevant standards and guidance.
• Until the conditions set out above are met, there is no requirement to make allowance for the developing European regulatory regime (Solvency II) and associated consequences when complying with the European Insurance Market Consistent Embedded Value (MCEV) Principles© or the European Embedded Value Principles (EEV).
This guidance reflects that the full implications of Solvency II are not known with sufficient certainty at this time.
7
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
EVs reported by more than 90 companies across the globe
0 5 10 15 20 25 30 35
Canada, Israel, South Africa
Japan
Asia-Pac excl. Japan
Europe
7
2
28
1
7
14
3
15
11
3
2
Number of companies reporting year-end 2012 embedded values
TEV EEV Principles MCEV Principles Other
Source: Towers Watson analysis 8
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Total reported EV approximately $900bn at year-end 2012
395
161
145
122
70
Reported EV by location of headquarters (USD bn)
Europe
Japan
China / Hong Kong
Rest of Asia-Pacific
Canada, South Africa,Israel
Source: Towers Watson analysis of company EV reports 9
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
10
EEVP & MCEVP trends
Source: Towers Watson Insights, 2012 Life supplementary reporting: Focus on EV/EEV/MCEV and wider metrics, May 2013
0
5
10
15
20
25
30
35
40
2004 2005 2006 2007 2008 2009 2010 2011 2012
EEV: top down & other EEV: market-consistent calibration MCEV Principles
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
MCEV technical issues
Equivalent annual cost of capital charge for NHR for MCEV Principles publications:
Extrapolation approach At YE12, changes to last liquidity point and convergence period by eight
companies Liquidity premium 2/3rds of companies applying illiquidity premium used method similar to
QIS5
Non-hedgeable risk (NHR):
Reference rate:
11
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
2012 EV/VNB Results for US Subsidiaries of European Multinationals
Multinational Change in EV Change in VNB Margin Allianz 16% -1.6% Aviva 73% -3.6% AXA -4% 0.8% Legal and General (Banner) -4% 1.1% Prudential UK (Jackson National) 13% -0.4% Zurich (Farmers New World) -7% 3.0%
12 Source: Towers Watson analysis of published year end 2012 EV reports
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
0
2
4
6
8
10
12
2006 2007 2008 2009 2010 2011 2012Solvency I ratios EC solvency ratios
Increased focus on risk and capital
Issues IGD/Solvency I not very risk based (particularly Pillar 1) Practice varies around EC disclosure EC: lack of disclosure of methodology, assumptions and sign off
Number of current CFO Forum members reporting Solvency I and Economic Capital Coverage Ratios
Source: Towers Watson analysis of company reports
13
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Increased focus on cash flow
1 1
5 4
5
7
10 11
13 13
0
2
4
6
8
10
12
14
2008 2009 2010 2011 2012
New business In-force business
Emergence of projected distributable profits (from the 39 EEVP/MCEVP companies)
Source: Towers Watson Insights, 2012 Life supplementary reporting: Focus on EV/EEV/MCEV and wider metrics, May 2013
Issues “Real world” or “risk neutral” Gross or net of required capital?
14
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Projected cash flow disclosures: Prudential
15
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Embedded value reporting in North America Is a new trend about to start?
16
towerswatson.com © 2013 Towers Watson. All rights reserved.
Proprietary and Confidential. For Towers Watson and Towers Watson client use only.
Improve construction/presentation of each metric
Metric Suggested improvement
Cash • Clearly define ‘cash’ • Net of required capital • Realistic (TEV style) cash flow projections
Capital • Regulatory and economic capital • Information on capital constraints at main entities
Profit • Based on IFRS • Split by main drivers (investment, insurance, expenses)
Value • Realistic (TEV style) cash flow projections • Discount at rate allowing for all risks (IDR) for central
value New business
• Value based on realistic cash flows with full (MCEV) allowance for risk
Sensitivities key to communicate risk
Bet
ter l
inks
bet
wee
n m
etric
s
17
towerswatson.com © 2013 Towers Watson. All rights reserved.
18
Contact
Dominique LeBel, FSA, FCIA, MAAA Towers Watson Director and Leader, Hartford Life Practice
860-843-7161 [email protected]
towerswatson.com Proprietary and Confidential. For Towers Watson and Towers Watson client use only. © 2013 Towers Watson. All rights reserved.